AAAAAA

   
Results: 1-25 | 26-37 |
Results: 26-37/37
HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION (BMT) FOR HEMATOLOGIC MALIGNANCIES
Authors: PIETRYGA D CASPER J GARBRECHT F CAMITTA B DROBYSKI W HOROWITZ M LAWTON C KEEVER C BAXTERLOWE L MURRAY K PIERCE K CADWALLADER S MCAULIFFE T FLOMENBERG N
Citation: D. Pietryga et al., HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION (BMT) FOR HEMATOLOGIC MALIGNANCIES, Blood, 84(10), 1994, pp. 10000339-10000339
EFFECT OF T-CELL DEPLETION AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON ENGRAFTMENT, RELAPSE, AND DISEASE-FREE SURVIVAL IN UNRELATED MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: DROBYSKI WR ASH RC CASPER JT MCAULIFFE T HOROWITZ MM LAWTON C KEEVER C BAXTERLOWE LA CAMITTA B GARBRECHT F PIETRYGA D HANSEN R CHITAMBAR CR ANDERSON T FLOMENBERG N
Citation: Wr. Drobyski et al., EFFECT OF T-CELL DEPLETION AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON ENGRAFTMENT, RELAPSE, AND DISEASE-FREE SURVIVAL IN UNRELATED MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 83(7), 1994, pp. 1980-1987
A NEW ASSAY SYSTEM FOR THE ESTIMATION OF RESIDUAL T-CELL SUBSETS IN T-CELL DEPLETED BONE-MARROW
Authors: KAWANISHI Y FLOMENBERG N KEEVER CA
Citation: Y. Kawanishi et al., A NEW ASSAY SYSTEM FOR THE ESTIMATION OF RESIDUAL T-CELL SUBSETS IN T-CELL DEPLETED BONE-MARROW, Human immunology, 37, 1993, pp. 151-151
IMPACT OF HLA DISPARITY IN BONE-MARROW
Authors: BAXTERLOWE LA CASPER J FLOMENBERG N DINAUER D CAMITTA B DROBYSKI W GARBRECHT F PIETRYGA D HOROWITZ M ANDERSON T CHITAMBER C HANSEN R LAWTON C BUNIN N KEEVER C PIERCE K ASH R
Citation: La. Baxterlowe et al., IMPACT OF HLA DISPARITY IN BONE-MARROW, The Journal of immunology, 150(8), 1993, pp. 321-321
SALVAGE IMMUNOTHERAPY USING DONOR LEUKOCYTE INFUSIONS AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - EFFICACY AND TOXICITY OF A DEFINED T-CELL DOSE
Authors: DROBYSKI WR KEEVER CA ROTH MS KOETHE S HANSON G MCFADDEN P GOTTSCHALL JL ASH RC VANTUINEN P HOROWITZ MM FLOMENBERG N
Citation: Wr. Drobyski et al., SALVAGE IMMUNOTHERAPY USING DONOR LEUKOCYTE INFUSIONS AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - EFFICACY AND TOXICITY OF A DEFINED T-CELL DOSE, Blood, 82(8), 1993, pp. 2310-2318
BONE-MARROW TRANSPLANTATION (BMT) FOR CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) USING UNRELATED DONORS
Authors: CASPER J CAMITTA B BAXTERLOWE LA BUNIN N ASH R PIETRYGA D GARBRECHT F MURRAY K LAWTON C TRUITT R KEEVER C FLOMENBERG N
Citation: J. Casper et al., BONE-MARROW TRANSPLANTATION (BMT) FOR CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) USING UNRELATED DONORS, Blood, 82(10), 1993, pp. 10000170-10000170
PHASE-III DOUBLE-BLIND TRIAL OF RHGM-CSF (SARGRAMOSTIN) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT)
Authors: NEMUNAITIS J ROSENFELD C ASH R FLOMENBERG N FRIEDMAN M DEEG J APPELBAUM F SINGER JW DALTON W ELFENBEIN G RIFKIN R RUBIN A AGOSTI J HAYES FA SHADDUCK RK
Citation: J. Nemunaitis et al., PHASE-III DOUBLE-BLIND TRIAL OF RHGM-CSF (SARGRAMOSTIN) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT), Blood, 82(10), 1993, pp. 10000286-10000286
UNRELATED DONOR MARROW TRANSPLANTATION (BMT) FOR CHILDREN WITH SEVEREAPLASTIC-ANEMIA (AA)
Authors: CAMITTA B CASPER J PIETRYGA D GARBRECHT F ASH R KEEVER C MURRAY K BAXTERLOWE L FLOMENBERG N
Citation: B. Camitta et al., UNRELATED DONOR MARROW TRANSPLANTATION (BMT) FOR CHILDREN WITH SEVEREAPLASTIC-ANEMIA (AA), Blood, 82(10), 1993, pp. 10000344-10000344
THERAPEUTIC PLASMA-EXCHANGE NOT EFFECTIVE IN THE MANAGEMENT OF TTP HUS FOLLOWING BONE-MARROW TRANSPLANTATION
Authors: SARODE R MCFARLAND JG FLOMENBERG N CASPER JT COHEN E DROBYSKI W HOROWITZ M CAMITTA B GARBRECHT F PIETRYGA D LAWTON C ASH R GOTTSCHALL J
Citation: R. Sarode et al., THERAPEUTIC PLASMA-EXCHANGE NOT EFFECTIVE IN THE MANAGEMENT OF TTP HUS FOLLOWING BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000419-10000419
IMPACT OF T-CELL DEPLETION AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON ENGRAFTMENT, RELAPSE AND DISEASE-FREE SURVIVAL IN UNRELATED MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: DROBYSKI WR ASH RC CASPER JT MCAULIFFE T HOROWITZ MM LAWTON C KEEVER C BAXTERLOWE LA CAMITTA B GARBRECHT F PIETRYGA D HANSEN R CHITAMBAR C ANDERSON T FLOMENBERG N
Citation: Wr. Drobyski et al., IMPACT OF T-CELL DEPLETION AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON ENGRAFTMENT, RELAPSE AND DISEASE-FREE SURVIVAL IN UNRELATED MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 82(10), 1993, pp. 10000423-10000423
EFFECT OF T-CELL SUBSET CONTENT ON ACUTE GRAFT-VS-HOST DISEASE FOLLOWING T-CELL DEPLETED BONE-MARROW TRANSPLANTATION
Authors: KAWANISHI Y FLOMENBERG N CRAIG A DROBYSKI W HOROWITZ M CASPER J CAMITTA B PIETRYGA D GARBRECHT F KEEVER CA
Citation: Y. Kawanishi et al., EFFECT OF T-CELL SUBSET CONTENT ON ACUTE GRAFT-VS-HOST DISEASE FOLLOWING T-CELL DEPLETED BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000423-10000423
MOLECULAR ANALYSIS OF T-CELL REPERTOIRE RECONSTITUTION AFTER BONE-MARROW TRANSPLANTATION - CORRELATION WITH GENERAL IMMUNE STATUS
Authors: GORSKI J YASSAI M KEEVER C FLOMENBERG N
Citation: J. Gorski et al., MOLECULAR ANALYSIS OF T-CELL REPERTOIRE RECONSTITUTION AFTER BONE-MARROW TRANSPLANTATION - CORRELATION WITH GENERAL IMMUNE STATUS, Blood, 82(10), 1993, pp. 10000518-10000518
Risultati: 1-25 | 26-37 |